You are viewing: US Diabetes Care Devices Market analysis
Part of: Diabetes Care Devices Market (Global)

The US Diabetes Care Devices Market was valued at $12020 Million in 2025 and projected to reach to $21321.2 Million by 2030, representing a compound annual growth rate of 12.1%. The US diabetes care devices market is positioned for sustained growth through 2030, driven by the escalating prevalence of diabetes and the shift toward preventive care management.

US Diabetes Care Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Diabetes Care Devices Market Trends and Insights

  • This expansion reflects the US's rising diabetes prevalence, increasing adoption of continuous glucose monitoring systems, and growing demand for insulin delivery devices.
  • The US market benefits from advanced healthcare infrastructure, strong reimbursement policies, and significant investment in diabetes management technologies. Driving the US market's 12.1% compound annual growth rate are technological innovations in glucose monitoring, expanding patient awareness, and the integration of digital health solutions.
  • The US leads in adoption of next-generation diabetes care devices, supported by favorable regulatory pathways and competitive market dynamics.
  • Between 2025 and 2030, the US is expected to capture substantial market share through both established players and emerging innovators focusing on user-friendly, connected devices..

Key Market Statistics

  • CAGR (2025-2030) 12.1% CAGR
  • Market Size, 2025 ~USD 12020 Million
  • Forecast, 2030 ~USD 21321.2 Million
  • Country US

US Diabetes Care Devices Market Overview

Market Valuation Growth :

The US diabetes care devices market is valued at $12,020 million in 2025 and is projected to reach $21,321.2 million by 2030, representing a robust 12.1% CAGR over the forecast period.

CGM System Adoption :

Continuous glucose monitoring systems are experiencing accelerated adoption across the US market, driven by improved accuracy, reduced costs, and increased insurance coverage for diabetes management solutions.

Insulin Delivery Innovation :

Advanced insulin delivery devices, including smart pens and automated insulin pumps, are gaining significant traction in the US market due to enhanced patient compliance and better glycemic control outcomes.

Healthcare Infrastructure Advantage :

The US benefits from advanced healthcare infrastructure, strong reimbursement policies, and high patient awareness, creating a favorable environment for diabetes care device adoption and market expansion.

US Diabetes Care Devices Market Dynamics

  • Technological advancements in continuous glucose monitoring and insulin delivery systems are reshaping treatment paradigms, with patients increasingly adopting connected devices that integrate with digital health platforms.
  • Reimbursement improvements and expanded insurance coverage are reducing financial barriers to adoption. Key growth drivers include the aging population, rising obesity rates, and growing demand for personalized diabetes management solutions.
  • The competitive landscape is intensifying as major medical device manufacturers invest in R&D and digital integration.
  • Regulatory support for innovative devices and the expansion of telehealth services further accelerate market penetration, positioning the US market as a leader in diabetes care device innovation and adoption..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US diabetes care devices market will grow from $12.02B in 2025 to $21.32B in 2030, representing a 12.1% CAGR.
    • The US market is driven by rising diabetes prevalence, technological innovation, and strong reimbursement coverage for advanced devices.
    • Continuous glucose monitoring and insulin delivery systems dominate the US market, with increasing integration of digital health platforms.
    • The US maintains competitive advantages through regulatory support, healthcare infrastructure, and high patient adoption rates for connected diabetes devices.

    Diabetes Care Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIABETES MANAGEMENT MOBILE APPLICATIONS (Product Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 12.3% from 2025 to 2030
    Largest Segment TYPE 2 DIABETES (Disease Type)
    Market Size Base Year (Billions) ~USD 34.27 (2025)
    Revenue Forecast (Billions) ~USD 61.2 (2030)
    Segments Covered Product Type, Type, Disease Type, Patient Care Settings

    US Diabetes Care Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product Type

    • Blood Glucose Monitoring System
    • Blood Glucose Monitoring Systems
    • Diabetes Management Mobile Applications
    • Insulin Delivery Devices

    By Type

    • Continuous Glucose Monitoring Systems
    • Disposable Insulin Pens
    • Insulin Pens
    • Insulin Pumps & Accessories
    • Insulin Syringes & Needles
    • Lancets/Lancing Devices
    • Other Insulin Delivery Devices
    • Pen Needles
    • Reusable Insulin Pens
    • Self-Monitoring Blood Glucose Systems
    • Test Strips/ Test Papers
    • Test Strips/Test Papers
    • Tethered Insulin Pumps
    • Tubeless Insulin Pumps

    By Disease Type

    • Type 1 Diabetes
    • Type 2 Diabetes

    By Patient Care Settings

    • Hospitals & Diabetes Specialty Clinics
    • Self/ Home Healthcare
    • Self/Home Healthcare

    Target Audience

    • Medical Device Manufacturers : Device makers need US market intelligence to benchmark competitive positioning, identify growth opportunities in CGM and insulin delivery segments, and optimize product development roadmaps for American consumers.
    • Healthcare Investors & PE Firms : Investment professionals require detailed US market data to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in the high-growth diabetes care devices sector.
    • Healthcare Providers & Hospital Systems : Hospital networks and clinics need market insights to make informed procurement decisions, understand device adoption trends, and align diabetes care programs with market-leading solutions and best practices.
    • Insurance & Reimbursement Specialists : Payers and insurance companies require market analysis to develop coverage policies, assess cost-effectiveness of new devices, and understand utilization patterns across the US diabetes care landscape.
    • Market Researchers & Consultants : Research firms and consulting organizations need comprehensive US market data to support client advisory work, validate market hypotheses, and provide evidence-based recommendations for healthcare strategy.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise valuation data for the US diabetes care devices market with verified CAGR of 12.1%, enabling accurate financial forecasting and investment decision-making through 2030.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to the US market, including key players, market share distribution, and strategic positioning within the rapidly evolving diabetes care device sector.
    • Segment-Specific Insights : Access detailed analysis of US market segments including CGM systems, insulin pumps, and glucose meters, with segment-level growth projections and adoption trends tailored to American healthcare dynamics.
    • Regulatory & Reimbursement Analysis : Gain comprehensive understanding of US FDA regulations, insurance coverage policies, and reimbursement landscape that directly impact market accessibility and device adoption rates.
    • Strategic Market Entry Planning : Leverage US-specific market data to develop targeted go-to-market strategies, identify partnership opportunities, and optimize product positioning for maximum market penetration and revenue growth.

    Frequently asked questions

    What is the current size of the US diabetes care devices market?

    The US diabetes care devices market is valued at $12,020 million in 2025 and is expected to reach $21,321.2 million by 2030.

    What is the projected growth rate for the US diabetes care devices market?

    The US diabetes care devices market is projected to grow at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2030.

    What are the main drivers of growth in the US diabetes care devices market?

    Key growth drivers in the US include rising diabetes prevalence, technological innovations in glucose monitoring, increased patient awareness, strong reimbursement policies, and the integration of digital health solutions.

    Which device types dominate the US diabetes care devices market?

    Continuous glucose monitoring systems and insulin delivery devices are the dominant segments in the US market, with growing adoption of connected and digital-enabled solutions.

    What factors give the US a competitive advantage in diabetes care devices?

    The US benefits from advanced healthcare infrastructure, favorable regulatory pathways, strong reimbursement coverage, high patient adoption rates, and significant investment in diabetes management innovation.

    RESEARCH METHODOLOGY

    The study involved four main activities to estimate the current size of the diabetes care devices market. First, extensive secondary research was conducted to gather information about the market, including related and parent markets. The next step was validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Both top-down and bottom-up methods were used to develop a comprehensive estimate of the overall market size. Lastly, market segmentation and data triangulation techniques were employed to determine the sizes of segments and subsegments within the market.

    Secondary Research

    The secondary research process involved extensive use of various sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the diabetes care devices market. It also helped obtain critical insights about key industry players, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.

    Primary Research

    In the primary research process, we conducted interviews with various sources from both the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts, including CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations involved in the diabetes care devices market, were interviewed. For the demand side, engagement with industry experts, purchase and sales managers, doctors, and personnel from research organizations was done. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.

    A breakdown of the primary respondents for the diabetes care devices market is provided below:

    Diabetes Care Devices Market

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the diabetes care devices market includes the following details.

    The market sizing was undertaken from the global side.

    Country-level Analysis: The size of the diabetes care devices market was determined from annual presentations by leading companies and publicly available secondary data. The share of products and services within the overall diabetes care devices market was calculated using secondary data and verified by primary participants to arrive at the total market size. Primary participants also further validated the data numbers.

    Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each stage, the assumptions and approaches were verified with industry experts contacted during primary research. Due to limitations in the data from secondary research, revenue estimates for individual companies (covering the overall diabetes care devices market and geographic market assessment) were determined based on a detailed analysis of their product offerings, geographic reach or strength (whether direct or through distributors or suppliers), and the market shares of leading players in specific regions and countries.

    Global Diabetes Care Devices Market Size: Bottom-up and Top-down Approach

    Diabetes Care Devices Market

    Data Triangulation

    After determining the overall size from the market size estimation process described above, the total market was divided into several segments and subsegments. The data triangulation and market breakdown procedures outlined below were applied, where appropriate, to complete the overall market analysis and obtain precise statistics for various segments. The data was triangulated by examining different factors and trends from both demand and supply perspectives. Additionally, the market size was validated using both the top-down and bottom-up approaches.

    Market Definition

    The diabetes care devices includes medical technologies and tools used for monitoring, managing, and treating diabetes. It features blood glucose monitoring systems (such as glucometers, continuous glucose monitors, test strips, and lancets), insulin delivery devices (including insulin pens, pumps, syringes, and automated delivery systems), and related accessories. These devices help track glucose accurately, deliver insulin effectively, and improve patient outcomes by enabling better disease control, reducing complications, and enhancing quality of life. The market serves patients, healthcare providers, and caregivers and is driven by technological innovations, the rising prevalence of diabetes, and increasing demand for connected, user-friendly solutions.

    Stakeholders

    • Diabetes Care Devices’ Manufacturing Companies
    • Contract Manufacturers
    • Distributors, Suppliers, and Channel Partners of Diabetes Care Devices
    • Senior Management
    • Finance Department
    • Procurement Department
    • Hospitals & Clinics
    • E-commerce and Digital Platforms
    • Retail Pharmacies and Supermarkets
    • Academic & Research Institutes
    • Trade Associations and Industry Bodies
    • Regulatory Bodies and Government Agencies
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, segment, analyse, and forecast the global diabetes care devices  market by product type, disease type, patient care settings, and region
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze micro markets concerning individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the diabetes care devices  market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries
    • To profile the key players in the diabetes care devices  market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the diabetes care devices  market

     

    Get the Full Diabetes Care Devices Market Report

    Full forecast, segment splits, and company analysis for all Diabetes Care Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status